[1] Nicholson TR, Carson A, Edwards MJ, Goldstein LH, Hallett M, Mildon B, Nielsen G, Nicholson C, Perez DL, Pick S, Stone J; and the FND-COM (Functional Neurological Disorders Core Outcome Measures) Group, FND-COM Group Collaborators are as Follows. Outcome measures for functional neurological disorder:a review of the theoretical complexities[J]. J Neuropsychiatry Clin Neurosci, 2020, 32:33-42. [2] Hallett M, Aybek S, Dworetzky BA, McWhirter L, Staab JP, Stone J. Functional neurological disorder:new subtypes and shared mechanisms[J]. Lancet Neurol, 2022, 21:537-550. [3] Schwingenschuh P, Espay AJ. Functional tremor[J]. J Neurol Sci, 2022, 435:120208. [4] Espay AJ, Aybek S, Carson A, Edwards MJ, Goldstein LH, Hallett M, LaFaver K, LaFrance WC Jr, Lang AE, Nicholson T, Nielsen G, Reuber M, Voon V, Stone J, Morgante F. Current concepts in diagnosis and treatment of functional neurological disorders[J]. JAMA Neurol, 2018, 75:1132-1141. [5] Tinazzi M, Morgante F, Marcuzzo E, Erro R, Barone P, Ceravolo R, Mazzucchi S, Pilotto A, Padovani A, Romito LM, Eleopra R, Zappia M, Nicoletti A, Dallocchio C, Arbasino C, Bono F, Pascarella A, Demartini B, Gambini O, Modugno N, Olivola E, Di Stefano V, Albanese A, Ferrazzano G, Tessitore A, Zibetti M, Calandra-Buonaura G, Petracca M, Esposito M, Pisani A, Manganotti P, Stocchi F, Coletti Moja M, Antonini A, Defazio G, Geroin C. Clinical correlates of functional motor disorders:an Italian multicenter study[J]. Mov Disord Clin Pract, 2020, 7:920-929. [6] Yin D, Wang H, Zhang YH, Ni Z, Chen Y, Chen XW, Dou RH, Hong Z, Kuang WH, Lin GZ, Wang YK, Wang HL, Xue Z, Xu SL, Chen W, Chen HB, Chen SD, Li CB, Wang G. Chinese expert consensus on the diagnosis and treatment of functional movement disorders[J]. Chongqing Yi Ke Da Xue Xue Bao, 2021, 46:732-736.[尹豆, 王含, 张玉虎, 倪臻, 陈燕, 陈先文, 窦荣花, 洪桢, 况伟宏,林国珍, 王玉凯, 王华龙, 薛峥, 许顺良, 陈伟, 陈海波, 陈生弟,李春波, 王刚. 功能性运动障碍的诊断与治疗中国专家共识[J].重庆医科大学学报, 2021, 46:732-736.] [7] Fahn S, Williams DT. Psychogenic dystonia[J]. Adv Neurol, 1988, 50:431-455. [8] Shill H, Gerber P. Evaluation of clinical diagnostic criteria for psychogenic movement disorders[J]. Mov Disord, 2006, 21:1163-1168. [9] Gupta A, Lang AE. Psychogenic movement disorders[J]. Curr Opin Neurol, 2009, 22:430-436. [10] Baslet G, Bajestan SN, Aybek S, Modirrousta M, D Clin Psy JP, Cavanna A, Perez DL, Lazarow SS, Raynor G, Voon V, Ducharme S, LaFrance WC Jr. Evidence-based practice for the clinical assessment of psychogenic nonepileptic seizures:a report from the American Neuropsychiatric Association Committee on research[J]. J Neuropsychiatry Clin Neurosci, 2021, 33:27-42. [11] Zanzmera P, Sharma A, Bhatt K, Patel T, Luhar M, Modi A, Jani V. Can short-term video-EEG substitute long-term video-EEG monitoring in psychogenic nonepileptic seizures:a prospective observational study[J]? Epilepsy Behav, 2019, 94:258-263. [12] LaFrance WC Jr, Baker GA, Duncan R, Goldstein LH, Reuber M. Minimum requirements for the diagnosis of psychogenic nonepileptic seizures:a staged approach. A report from the International League Against Epilepsy Nonepileptic Seizures Task Force[J]. Epilepsia, 2013, 54:2005-2018. [13] Gasparini S, Beghi E, Ferlazzo E, Beghi M, Belcastro V, Biermann KP, Bottini G, Capovilla G, Cervellione RA, Cianci V, Coppola G, Cornaggia CM, De Fazio P, De Masi S, De Sarro G, Elia M, Erba G, Fusco L, Gambardella A, Gentile V, Giallonardo AT, Guerrini R, Ingravallo F, Iudice A, Labate A, Lucenteforte E, Magaudda A, Mumoli L, Papagno C, Pesce GB, Pucci E, Ricci P, Romeo A, Quintas R, Sueri C, Vitaliti G, Zoia R, Aguglia U. Management of psychogenic non-epileptic seizures:a multidisciplinary approach[J]. Eur J Neurol, 2019, 26:205-e15. [14] Nass RD, Sassen R, Elger CE, Surges R. The role of postictal laboratory blood analyses in the diagnosis and prognosis of seizures[J]. Seizure, 2017, 47:51-65. [15] Wang XM, Liao LJ, Wang QX. Research progress the pathogenesis of fibromyalgia[J]. Tong Ji Da Xue Xue Bao (Yi Xue Ban), 2020, 41:518-522[.王小梅, 廖丽君, 王清秀. 纤维肌痛症发病机制的研究进展[J]. 同济大学学报(医学版), 2020, 41:518-522.] [16] Littlejohn G, Guymer E. Key milestones contributing to the understanding of the mechanisms underlying fibromyalgia[J]. Biomedicines, 2020, 8:223. [17] Phansalkar R, Lockman AJ, Bansal S, Moss HE. Management of functional vision disorders[J]. Curr Neurol Neurosci Rep, 2022, 22:265-273. [18] Bengtzen R, Woodward M, Lynn MJ, Newman NJ, Biousse V. The "sunglasses sign" predicts nonorganic visual loss in neuro-ophthalmologic practice[J]. Neurology, 2008, 70:218-221. [19] Baguley DM, Cope TE, McFerran DJ. Functional auditory disorders[J]. Handb Clin Neurol, 2016, 139:367-378. [20] American Psychiatric Association. Diagnostic and statistical manual of mental disorders[M]. 5th ed. Washington DC:American Psychiatric Association, 2013:191-192. statistical [21] World Health Organization. International classification of diseases and related health problems[M/OL]. 11th Revision (ICD-11), 2019[2023-01-01]. https://icd.who.int/browse11/l-m/en.postural-perceptual dizziness[J]. Semin [22] Staab JP. Persistent Neurol, 2020, 40:130-137. A, Horii A, Jacob R, Strupp M, [23] Staab JP, Eckhardt-Henn Brandt T, Bronstein A. Diagnostic criteria for persistent postural-perceptual dizziness (PPPD):consensus document of the committee for the Classification of Vestibular Disorders of the Bárány Society[J]. J Vestib Res, 2017, 27:191-208. [24] Pennington C, Newson M, Hayre A, Coulthard E. Functional cognitive disorder:what is it and what to do about it[J]? Pract Neurol, 2015, 15:436-444. [25] McWhirter L, Ritchie C, Stone J, Carson A. Functional cognitive disorders:a systematic review[J]. Lancet Psychiatry, 2020, 7:191-207. [26] Ball HA, McWhirter L, Ballard C, Bhome R, Blackburn DJ, Edwards MJ, Fleming SM, Fox NC, Howard R, Huntley J, Isaacs JD, Larner AJ, Nicholson TR, Pennington CM, Poole N, Price G, Price JP, Reuber M, Ritchie C, Rossor MN, Schott JM, Teodoro T, Venneri A, Stone J, Carson AJ. Functional cognitive disorder:dementia's blind spot[J]. Brain, 2020, 143:2895-2903. [27] Dimsdale JE, Creed F, Escobar J, Sharpe M, Wulsin L, Barsky A, Lee S, Irwin MR, Levenson J. Somatic symptom disorder:an important change in DSM[J]. J Psychosom Res, 2013, 75:223-228. [28] Maggio J, Alluri PR, Paredes-Echeverri S, Larson AG, Sojka P, Price BH, Aybek S, Perez DL. Briquet syndrome revisited:implications for functional neurological disorder[J]. Brain Commun, 2020, 2:fcaa156. [29] Daum C, Hubschmid M, Aybek S. The value of ‘positive’ clinical signs for weakness, sensory and gait disorders in conversion disorder:a systematic and narrative review[J]. J Neurol Neurosurg Psychiatry, 2014, 85:180-190. [30] Teodoro T, Cunha JM, Abreu LF, Yogarajah M, Edwards MJ. Abnormal eye and cranial movements triggered by examination in people with functional neurological disorder[J]. Neuroophthalmology, 2018, 43:240-243. [31] Park JE, Maurer CW, Hallett M. The "Whack-a-Mole" sign in functional movement disorders[J]. Mov Disord Clin Pract, 2015, 2:286-288. [32] Wang G. Diagnostic approaches of neurology[M]. Shanghai:Shanghai Jiao Tong University Press, 2022:175-176[.王刚. 神经病学诊断思路[M]. 上海:上海交通大学出版社, 2022:175-176.] [33] LaFaver K, Maurer CW, Nicholson TR, Perez DL. Functional movement disorder[M]. Switzerland:Humana Cham, 2022:172-173. [34] Stone J, Vermeulen M. Functional sensory symptoms[J]. Handb Clin Neurol, 2016, 139:271-281. |